Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience

被引：0
|
作者：
Monzo, L. [1 ]
Cicogna, F. [2 ]
Tota, C. [2 ]
Petronilli, V. [2 ]
Mennuni, S. [2 ]
De Ruvo, E. [2 ]
Calo, L. [2 ]
机构：
[1] Sapienza Univ Rome, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Rome, Italy
[2] Polyclin Casilino Rome, Dept Cardiol, Rome, Italy
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：42 / 43
页数：2
相关论文
共 50 条
  • [21] Real world experience of sacubitril and valsartan in patients with heart failure with reduced ejection fraction
    Ganesananthan, S.
    Shah, N.
    Shah, P.
    Phillips, J.
    Elsayed, H.
    Yousef, Z.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 222 - 222
  • [22] Sacubitril/Valsartan in real world heart failure proctice in Asia
    Chu, P. H.
    Hsia, F. C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 412 - 412
  • [23] Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF
    Felker, G. Michael
    Butler, Javed
    Ibrahim, Nasiren E.
    Pina, Ileana L.
    Maisel, Alan
    Bapat, Devavrat
    Camacho, Alexander
    Ward, Jonathan H.
    Williamson, Kristin M.
    Solomon, Scott D.
    Januzzi, James L.
    CIRCULATION, 2021, 144 (02) : 180 - 182
  • [24] HEALTH OUTCOMES PROJECTIONS OF SACUBITRIL/VALSARTAN IN THE TREATMENT OF HEART FAILURE IN A REAL-WORLD POPULATION IN PORTUGAL
    Afonso-Silva, M.
    Laires, P. A.
    VALUE IN HEALTH, 2019, 22 : S547 - S548
  • [25] Dose titration of sacubitril/valsartan for heart failure with reduced ejection fraction: a real-world study
    Wang, Chen
    Lin, Zongwei
    Miao, Dongxia
    Zhang, Hui
    Fu, Kang
    Zhang, Xinyu
    Xiao, Jie
    Hu, Yue
    Sun, Yijun
    Wang, Fen
    Lu, Huixia
    Ji, Xiaoping
    ESC HEART FAILURE, 2023, 10 (03): : 1961 - 1971
  • [26] Beneficial Effects of Sacubitril/Valsartan at Low Doses in an Asian Real-World Heart Failure Population
    Hu, Jingwen
    Wu, Yucheng
    Zhou, Xiujuan
    Wang, Xiaozhi
    Jiang, Wanying
    Huo, Junyu
    Shan, Qijun
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 76 (04) : 445 - 451
  • [27] Sacubitril/valsartan use in a real-world population of patients with heart failure and reduced ejection fraction
    Mapelli, Massimo
    Salvioni, Elisabetta
    de Martino, Fabiana
    Mattavelli, Irene
    Bonomi, Alice
    Sassi, Valentina
    Gugliandolo, Paola
    Vignati, Carlo
    Magini, Alessandra
    Rovai, Sara
    Paolillo, Stefania
    Agostoni, Piergiuseppe
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2020, 21 (11) : 882 - 888
  • [28] Effect of sacubitril/valsartan therapy on risk stratification biomarkers in a real-world heart failure population
    Barrett, M. J.
    Hammond, M.
    Zhou, S.
    Hanlon, R. O.
    Campbell, P.
    Mcdonald, K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 585 - 586
  • [29] Sacubitril/valsartan improves cardiac function in Chinese patients with heart failure: a real-world study
    Chen, Wenwen
    Liu, Yanlin
    Li, Yuanmin
    Dang, Heqin
    ESC HEART FAILURE, 2021, 8 (05): : 3783 - 3790
  • [30] Use of sacubitril-valsartan in heart failure with reduced ejection fraction: real world experience
    Ferreira, F. A. C.
    Cristina, S.
    Raposo, A. F.
    Albuquerque, E. M.
    Nabais, I.
    Matias, C. S.
    Nogueira, M. A.
    Vasconcellos, R. C. A.
    Proenca, G. M. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 228 - 229
12345